THE PRIMEBODYRX PLATFORM
One login runs the entire longevity practice. Everything else is a vendor.
Wholesale ordering across a U.S. 503A/503B pharmacy network. Ship-to-patient fulfillment. A full clinical suite with protocol automation. Point-of-decision financing that gets the practice paid in full, same visit. Seven years of engineering, running live on 400+ physician-led practices today.
Practices use it to run and grow. Associates earn recurring revenue for the life of every account they open on it. Same platform, two ways in.
Associates open practice accounts and earn on every order for the life of the account, plus MedFiAdvance residuals underneath.
See the Associate ProgramRespect is the difference
This category has a shark problem, and we are willing to name it. The longevity space is crowded with fakes, hype merchants, and vendors who treat a medical practice's time as if it were free. Practices are chased by appointment setters, buried in software they didn't ask for, and sold features that don't exist by people who will not be around in a year. We operate differently, and the differences are deliberate.
- Wholesale only, to approved practices. We sell wholesale to verified medical practices and providers. We do not sell direct to the consumer. The practice owns its patients; we power the practice. That line does not move.
- We respect practice time. A practice owner's hours belong to patients, staff, and growth. Every promise we make is either demonstrated in a live session or it does not get made. No pressure funnels, no mystery pricing, no chasing.
- Verification over adjectives. We would rather hand you a live demonstration and a documented sourcing standard than a page of superlatives. In a space full of sharks, the highest form of service and technology is the kind you can check.
- Infrastructure over trends. Seven years of technology and two-plus years of live operation happen by building quietly, correctly, and to documented standards: LegitScript verified, HIPAA-oriented architecture, board-certified physician oversight, sourcing exclusively through U.S. 503A/503B pharmacies, and U.S. practices only.
We are particular about the practices we serve, and the practices on the platform prefer it that way. Approval is verification, not a paywall: a practice is onboarded as a verified medical business, and wholesale access is granted to that practice alone. The standards are part of the product.
Not a debut. A record.
PrimeBodyRX is a B2B healthcare commerce and distribution platform — one operating environment where a practice reviews, orders, uses, and distributes GLP-1s, peptides, hormone replacement, IV therapies, and the wider longevity formulary.
Built first
Seven years of technology, built quietly before the category had a name.
Live for real
Two-plus years in live operation on real practices — not a plan.
Proven at scale
400+ doctor offices running on it today, and more joining every day.
Seasoned entrepreneur partners built this on their own capital, not a raise. Every claim here — sourcing, clinical tools, fulfillment, financing — is demonstrated live, on screen, in a professional appointment you can book today.
The frustration every longevity practice already lives with
You know this story already, because you are living it. One portal for supplements. Another for GLP-1s. A third for peptides. A lab system for diagnostics, spreadsheets for reconciliation, and a financing phone number that never answers. The practice is not slow. The vendor stack is slow.
The single-pharmacy hostage
Most ordering platforms are a front for one pharmacy. Every backorder, price increase, or capacity problem there becomes the practice's problem, and programs go dark through no fault of the practice.
The gray-market leak
Patients buy mystery vials from anonymous websites with no chain of custody. The practice loses revenue, the patient loses protection, and the category loses credibility.
The walk-out at the price tag
The patient wants the program, hesitates at the number, and leaves to think about it. Most never come back, and the practice absorbs the loss as a cost of doing business.
The operational tax
Even when everything works, the owner spends evenings as a supply-chain manager, a reimbursement chaser, and a spreadsheet accountant instead of a clinician and a business builder.
The answer, point by point
- One platform replaces the patchwork. Storefront, formulary, ordering, clinical tools, fulfillment, financing, and analytics live under one login with one accountable partner.
- Multi-pharmacy sourcing ends the hostage situation. Orders route across a U.S. 503A/503B network, so no single supplier's quarter can shut down a practice's programs.
- Documented sourcing replaces the gray market. Chain of custody through licensed U.S. pharmacies gives the practice the compliant path patients are asking for.
- Integrated patient financing ends the walk-out. Approval in minutes, the practice paid upfront and in full, and the patient on a plan they can accept on the same visit.
- The operational tax comes down. Live dashboards, managed fulfillment, and one accountable relationship replace five unaccountable ones.
The platform in full, module by module
This is the honest tour — the same one a practice receives in a professional appointment. Not a summary of features: the map of an operating environment, module by module and tool by tool, because a practice deciding where to run its longevity programs deserves to know exactly what it is standing on.
Insider tip: the Demo walks this exact tour live, on screen, with a senior operator.
Financing, built into the workflow
Every practice knows the moment: the patient who wants the program and hesitates at the number. MedFiAdvance is the category’s only patient-financing engine built directly into the ordering workflow — approval in minutes, no hold on the patient’s card, and the practice paid in full, same visit.
Numbers that appear once in a career
The global GLP-1 weight-loss market stands near $60 billion and is projected to reach $150 to $190 billion by the early 2030s — compound annual growth in the range of 12 to 18 percent. The United States accounts for more than half of global demand, and J.P. Morgan forecasts the broader incretin market approaching $200 billion by 2030. Around that core, peptides, hormone optimization, IV therapy, and longevity protocols are compounding into one of the largest service categories in American medicine.
Demand is exploding while supply stays fragmented. The largest practitioner platforms do not carry compounded GLP-1s, peptides, and financing in one environment. Pharmacy-backed operations impose single-supplier lock-in. Lab portals route pharmacy outside the product. The second slot in the B2B longevity platform category is effectively vacant, and the infrastructure that wins this category will be chosen over the next 24 months.
PrimeBodyRX enters that window with a head start no competitor can manufacture: seven years of technology, a platform live for more than two, and over four hundred doctor offices already operating on it. Onboarding is measured in days. The roadmap extends the same rails — telehealth integrations, additional 503A/503B/cGMP pharmacy sources, API integrations, category expansion, doctor upsell and patient-pay support, automated CRM sales expansion, and partner storefronts running on the platform's own architecture.
The timing question for a practice is simple. The category arrives whether or not any individual practice prepares for it. The practices that standardize on one platform now will hold the operating-cost and sourcing advantages for the life of their programs.
Three channels. One flywheel.
The practices
Physicians, medspa owners, and clinic operators who need what the category demands — wholesale pricing, dependable multi-pharmacy sourcing, clinical tools, ship-to-patient fulfillment, and integrated financing — delivered as one partnership instead of a patchwork. The practice keeps its patients, its brand, and its clinical judgment. The platform carries the operational weight.
The Associates
Corporate pharmacy sales professionals who want out of B2C risk and exposure, entrepreneurs ready to build, and fitness coaches and people who’ve lived this path and want to represent best-in-class products and services — without the exposure of building a consumer brand: the ad spend, the platform bans, the liability, the compliance surface. A B2B relationship business with real infrastructure behind it.
The partners
Partner companies and vendors build their own storefronts and businesses on the platform's commerce and distribution architecture. Every partner that goes live adds demand, volume, and strength to the same rails. Practices order, the network expands, partners come online — the flywheel compounds.
Structural advantages
Multi-source supply that stays available when single-supplier platforms go dark. Clinical intelligence embedded where the ordering happens. Scalable distribution without re-platforming. Recurring revenue that compounds rather than resets. And financing as a moat — MedFiAdvance converts the patients other platforms lose.
One operating environment for a longevity practice
Taken together, the modules are the operating system for a longevity practice: the front door where the team orders, the sourcing that keeps the shelves full, the clinical suite that keeps the medicine precise, the fulfillment that reaches the patient, the financing that closes the treatment plan, and the dashboard that shows the owner the business. No practice should have to assemble this by hand, reconcile it by spreadsheet, and defend it in four support queues. PrimeBodyRX exists so that no practice has to.
The competitive position is structural, not rhetorical. Supplement marketplaces do not carry the compounds. Single-pharmacy operations impose the lock-in. Lab portals route the pharmacy outside the product. No one else combines multi-pharmacy sourcing, the clinical suite, ship-to-patient fulfillment, and integrated patient financing in one environment — because building it required capital, patience, and operators who had done it before. It is built. It is live. It is proven across four hundred offices. And it is demonstrated, not described.
Not just a link. A professional channel.
PrimeBodyRX opens the Associate channel to corporate pharmacy sales professionals who want out of B2C risk and exposure, entrepreneurs ready to build, and fitness coaches and people who’ve lived this path and want to represent best-in-class products and services — through a B2B channel, without building a consumer brand.
This is not just a link and a commission, and it is not a pyramid of paperwork. It is a professional channel with real infrastructure: the Associate introduces practices to a platform they genuinely need, and the platform's partnership team carries onboarding, clinical support, fulfillment, and service. The Associate builds durable business relationships, and recurring revenue runs for the life of every account opened.
Apply to become an Associate →
Ground-floor access
A multi-billion-dollar category that is still being organized — with a platform that already runs over four hundred doctor offices.
None of the consumer risk
No inventory, no fulfillment, no consumer-brand exposure, no ad-spend arms race. The platform carries the operational and compliance weight.
We don’t just sell longevity. We live it.
When we’re not on the phone or on a plane to a practice, this is the actual life — the run with your wife, the mat at sunrise, the call taken from the water.
IN CLOSING · THE DAILY BACK-OFFICE DEMO
You found us. That is the whole announcement.
One platform, front door to back office — seven years of technology, 400+ doctor offices, and a professional appointment on the real platform with the senior team whenever you are ready. Today is simply the day your search ended.
Request received.
The senior team will reach out to schedule — typically same-day, always this week. Check your email and phone.